Crisaborole Ointment for Skin Toxicity Induced by Cetuximab

NCT06118047 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer
Cetuximab
Skin Toxicity

Interventions

DRUG: Crisaborole Ointment
DRUG: Cetuximab

Sponsor

Sun Yat-sen University